BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23902989)

  • 21. Biochemical properties of the superficial masseter muscle in the aging rat.
    Miyata H; Sugiura T; Kawai Y
    Arch Ital Biol; 1998 Jan; 136(1):71-5. PubMed ID: 9492946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Eukarion-134 on Akt-mTOR signalling in the rat soleus during 7 days of mechanical unloading.
    Kuczmarski JM; Hord JM; Lee Y; Guzzoni V; Rodriguez D; Lawler MS; Garcia-Villatoro EL; Holly D; Ryan P; Falcon K; Garcia M; Janini Gomes M; Fluckey JD; Lawler JM
    Exp Physiol; 2018 Apr; 103(4):545-558. PubMed ID: 29315934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypoxia exposure on the phenotypic adaptation in remodelling skeletal muscle submitted to functional overload.
    Chaillou T; Koulmann N; Meunier A; Malgoyre A; Serrurier B; Beaudry M; Bigard X
    Acta Physiol (Oxf); 2013 Dec; 209(4):272-82. PubMed ID: 23621297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fish Protein Promotes Skeletal Muscle Hypertrophy via the Akt/mTOR Signaling Pathways.
    Morisasa M; Yoshida E; Fujitani M; Kimura K; Uchida K; Kishida T; Mori T; Goto-Inoue N
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(1):23-31. PubMed ID: 35228492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
    Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
    Wu Y; Wang BX; Guo YY; Wang YQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human oro-facial and masticatory muscles with respect to fibre types, myosins and capillaries. Morphological, enzyme-histochemical, immuno-histochemical and biochemical investigations.
    Stål P
    Swed Dent J Suppl; 1994; 98():1-55. PubMed ID: 7801228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unloaded shortening velocities of rabbit masseter muscle fibres expressing skeletal or alpha-cardiac myosin heavy chains.
    Sciote JJ; Kentish JC
    J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):659-67. PubMed ID: 8734979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro.
    Torgan CE; Daniels MP
    Mol Biol Cell; 2001 May; 12(5):1499-508. PubMed ID: 11359938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral effect of a unilateral occlusal splint on the expression of myosin heavy-chain isoforms in rat deep masseter muscle.
    Muller J; Vayssiere N; Muller A; Marti-Mestres G; Mornet D
    Arch Oral Biol; 2000 Dec; 45(12):1017-24. PubMed ID: 11084140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximal lengthening contractions induce different signaling responses in the type I and type II fibers of human skeletal muscle.
    Tannerstedt J; Apró W; Blomstrand E
    J Appl Physiol (1985); 2009 Apr; 106(4):1412-8. PubMed ID: 19112158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker.
    Xu T; Lin T; Xie J; Ren H; Chen N; Wang W
    Ren Fail; 2019 Nov; 41(1):267-277. PubMed ID: 30982374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abundant expression of myosin heavy-chain IIB RNA in a subset of human masseter muscle fibres.
    Horton MJ; Brandon CA; Morris TJ; Braun TW; Yaw KM; Sciote JJ
    Arch Oral Biol; 2001 Nov; 46(11):1039-50. PubMed ID: 11543711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
    Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
    J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of changes in food consistency on NADH-ubiquinone oxidoreductase activity and levels of mRNA for ND1, 51kDa, 75kDa and myosin heavy chain isoforms in two different portions of rat masseter muscle.
    Ide Y; Sato I
    Okajimas Folia Anat Jpn; 2006 Aug; 83(2):61-71. PubMed ID: 16944839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional overload increases beta-MHC promoter activity in rodent fast muscle via the proximal MCAT (betae3) site.
    Giger JM; Haddad F; Qin AX; Baldwin KM
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C518-27. PubMed ID: 11832337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.
    Pallafacchina G; Calabria E; Serrano AL; Kalhovde JM; Schiaffino S
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9213-8. PubMed ID: 12084817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcineurin activation influences muscle phenotype in a muscle-specific fashion.
    Talmadge RJ; Otis JS; Rittler MR; Garcia ND; Spencer SR; Lees SJ; Naya FJ
    BMC Cell Biol; 2004 Jul; 5():28. PubMed ID: 15282035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.